Nintedanib + Nintedanib Esilate

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
NINTEDANIB ACCORDCZ ES EU LV
  • capsule ×10 Nintedanib Esilate
  • capsule ×7 Nintedanib 100 mg
  • capsule ×5 Nintedanib 150 mg
  • unknown Nintedanib
Accord Healthcare S.L.U., Barcelona
Vargatef 100mg capsulesCZ ES EU GB LV
  • capsule ×5 Nintedanib 100 mg
  • capsule ×4 Nintedanib Esilate
  • capsule ×3 Nintedanib 150 mg
  • unknown Nintedanib
BOEHRINGER INGELHEIM ITALIA S.P.A, REGGELLO/FIRENZE
NINTEDANIB VIATRISCZ ES EU LV
  • capsule ×4 Nintedanib Esilate
  • capsule ×3 Nintedanib 100 mg
  • capsule ×3 Nintedanib 150 mg
  • unknown Nintedanib
VIATRIS LIMITED, Dublin
NINTEDANIB GLENMARKCZ ES
  • capsule ×3 Nintedanib Esilate 120.41 mg
  • capsule ×3 Nintedanib Esilate 180.61 mg
  • capsule Nintedanib 100 mg
  • capsule Nintedanib 150 mg
Glenmark Pharmaceuticals s.r.o., Praha
NINTEDANIB SANDOZCZ ES
  • capsule ×2 Nintedanib Esilate 120.4 mg
  • capsule ×2 Nintedanib Esilate 180.6 mg
  • capsule Nintedanib 100 mg
  • capsule Nintedanib 150 mg
Sandoz s.r.o., Praha
NINTEDANIB TEVACZ ES
  • capsule ×2 Nintedanib Esilate 120.4 mg
  • capsule ×2 Nintedanib Esilate 180.6 mg
  • capsule Nintedanib 100 mg
  • capsule Nintedanib 150 mg
Teva Pharmaceuticals CR, s.r.o., Praha

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.